Contact us: 206.543.3620 | email@example.com
Research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets.
Results in Open Forum Infectious Diseases show hydroxychloroquine does not protect people from the novel coronavirus.
The latest analysis by Institute of Health Metrics and Sciences suggests a perfect storm of aggravating factors.
Changes observed in the nuclei of cells emerging in mouse embryos will chart genomics of mammalian development.
Teams in Seattle and Cleveland are pursuing an experiment to regenerate crucial cells and create a new therapy model.
UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.
These National Institutes of Health grants will support trailblazing ideas for solving critical questions in biomedical science.
In a large U.S. trial, more than 70% of patients randomized to receive antibiotics ultimately avoided surgery, investigators found.
The role in a national trial could validate the technology as a predictor for drug therapies’ effectiveness against patients’ kidney diseases.
It's something that humans and hibernating squirrels have in common: Iodide dampens harm of stress-induced inflammation.